How the fanconi anemia pathway guards the genome.

Fanconi Anemia (FA) is an inherited genomic instability disorder, caused by mutations in genes regulating replication-dependent removal of interstrand DNA crosslinks. The Fanconi Anemia pathway is thought to coordinate a complex mechanism that enlists elements of three classic DNA repair pathways, namely homologous recombination, nucleotide excision repair, and mutagenic translesion synthesis, in response to genotoxic insults. To this end, the Fanconi Anemia pathway employs a unique nuclear protein complex that ubiquitinates FANCD2 and FANCI, leading to formation of DNA repair structures. Lack of obvious enzymatic activities among most FA members has made it challenging to unravel its precise modus operandi. Here we review the current understanding of how the Fanconi Anemia pathway components participate in DNA repair and discuss the mechanisms that regulate this pathway to ensure timely, efficient, and correct restoration of chromosomal integrity.

[1]  A. D’Andrea,et al.  The Fanconi Anemia/BRCA pathway: new faces in the crowd. , 2005, Genes & development.

[2]  Weidong Wang.  Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins , 2007, Nature Reviews Genetics.

[3]  A. Jetten,et al.  RAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage sites. , 2008, Cancer letters.

[4]  C. Mathew,et al.  The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J , 2005, Nature Genetics.

[5]  C. McKerlie,et al.  Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. , 2003, Human molecular genetics.

[6]  R. Moses,et al.  Positional cloning of a novel Fanconi anemia gene, FANCD2. , 2001, Molecular cell.

[7]  P. Sung,et al.  Mechanism of homologous recombination: mediators and helicases take on regulatory functions , 2006, Nature Reviews Molecular Cell Biology.

[8]  Weidong Wang.  A major switch for the Fanconi anemia DNA damage–response pathway , 2008, Nature Structural &Molecular Biology.

[9]  Hans Joenje,et al.  Fanconi anemia and DNA replication repair. , 2007, DNA repair.

[10]  W. R. Shannon,et al.  Cloning of cDNAs for Fanconi's anaemia by functional complementation , 1992, Nature.

[11]  M. Grompe,et al.  Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. , 2003, Genes & development.

[12]  F. Couch,et al.  Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers , 2008, Nature.

[13]  K. J. Patel,et al.  The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. , 2004, Molecular cell.

[14]  A. Venkitaraman,et al.  Abnormal Cytokinesis in Cells Deficient in the Breast Cancer Susceptibility Protein BRCA2 , 2004, Science.

[15]  H. Kook.  Fanconi anemia: Current management , 2005, Hematology.

[16]  S. Boulton,et al.  C. elegans: a model of Fanconi anemia and ICL repair. , 2009, Mutation research.

[17]  Anindya Dutta,et al.  UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. , 2006, Molecular cell.

[18]  B. Alter.  Fanconi's anemia and malignancies , 1996, American journal of hematology.

[19]  Hans Joenje,et al.  The Fanconi anaemia group G gene FANCG is identical with XRCC9 , 1998, Nature Genetics.

[20]  A. Auerbach.  A test for Fanconi's anemia. , 1988, Blood.

[21]  W. R. Shannon,et al.  Cloning of cDNAs for Fanconi's anaemia by functional complementation , 1992, Nature.

[22]  C. Mathew,et al.  Identification of the Fanconi Anemia Complementation Group I Gene, FANCI , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[23]  A. Consiglio,et al.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells , 2009, Nature.

[24]  I. M. Jones,et al.  Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis , 2007, Nucleic acids research.

[25]  J. Pereira-Leal,et al.  The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway , 2005, Nature Structural &Molecular Biology.

[26]  P. Rosenberg,et al.  Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2 , 2006, Journal of Medical Genetics.

[27]  W. Lambert,et al.  Nonerythroid αII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links , 2003, Journal of Cell Science.

[28]  S. Gygi,et al.  Regulation of monoubiquitinated PCNA by DUB autocleavage , 2006, Nature Cell Biology.

[29]  Boris Pfander,et al.  RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO , 2002, Nature.

[30]  N. Alon,et al.  Erratum: Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA , 1996, Nature Genetics.

[31]  K. Hofmann.  Ubiquitin-binding domains and their role in the DNA damage response. , 2009, DNA repair.

[32]  D. Livingston,et al.  The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Min Huang,et al.  Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. , 2009, Developmental cell.

[34]  J. Dalle.  HSCT for Fanconi anemia in children: factors that influence early and late results , 2008, Bone Marrow Transplantation.

[35]  J. Hoeijmakers,et al.  Fanconi Anemia (Cross)linked to DNA Repair , 2005, Cell.

[36]  S. Jentsch,et al.  PCNA, the Maestro of the Replication Fork , 2007, Cell.

[37]  C. Mathew,et al.  A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M , 2005, Nature Genetics.

[38]  H. Kitao,et al.  Fanconi anemia: genetic analysis of a human disease using chicken system , 2007, Cytogenetic and Genome Research.

[39]  C. Bishop,et al.  A novel ubiquitin ligase is deficient in Fanconi anemia , 2003, Nature Genetics.

[40]  A. Horwitz,et al.  Direct DNA Binding Activity of the Fanconi Anemia D2 Protein* , 2005, Journal of Biological Chemistry.

[41]  M. Babu,et al.  Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. , 2008, Molecular cell.

[42]  G. Kupfer,et al.  ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function. , 2009, Blood.

[43]  S. Fagerlie,et al.  Impaired Type I IFN-Induced Jak/STAT Signaling in FA-C Cells and Abnormal CD4+ Th Cell Subsets in Fancc−/− Mice1 , 2004, The Journal of Immunology.

[44]  A. Constantinou,et al.  Remodeling of DNA replication structures by the branch point translocase FANCM , 2008, Proceedings of the National Academy of Sciences.

[45]  Susan M. Gordon,et al.  Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. , 2003, Blood.

[46]  M. Sasaki.  Is Fanconi's anaemia defective in a process essential to the repair of DNA cross links? , 1975, Nature.

[47]  A. D’Andrea,et al.  Chk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway , 2007, Molecular and Cellular Biology.

[48]  Katsuhiro Hanada,et al.  XPF-ERCC1 Participates in the Fanconi Anemia Pathway of Cross-Link Repair , 2009, Molecular and Cellular Biology.

[49]  A. D’Andrea,et al.  Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. , 2005, Blood.

[50]  A. D’Andrea,et al.  Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance , 2006, Molecular and Cellular Biology.

[51]  L. Thompson,et al.  Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights. , 2009, Mutation research.

[52]  P. Rosenberg,et al.  Cancer in Fanconi anemia. , 2003, Blood.

[53]  S. Ganesan,et al.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. , 2001, Molecular cell.

[54]  Alan Ashworth,et al.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.

[55]  D. Sgroi,et al.  BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function , 2001, Cell.

[56]  T. Mak,et al.  Brca2 Deficiency Does Not Impair Mammary Epithelium Development but Promotes Mammary Adenocarcinoma Formation in p53+/− Mutant Mice , 2004, Cancer Research.

[57]  A. D’Andrea,et al.  The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly. , 2008, DNA repair.

[58]  Richard D. Wood,et al.  Repair of an Interstrand DNA Cross-link Initiated by ERCC1-XPF Repair/Recombination Nuclease* , 2000, The Journal of Biological Chemistry.

[59]  E. Spiteri,et al.  FANCI is a second monoubiquitinated member of the Fanconi anemia pathway , 2007, Nature Structural &Molecular Biology.

[60]  H. Joenje,et al.  Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice. , 2002, Human molecular genetics.

[61]  H. Arakawa,et al.  Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. , 2005, Cancer research.

[62]  J. Ott,et al.  The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia , 2005, Nature Genetics.

[63]  F. Rosselli,et al.  BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks , 2004, The EMBO journal.

[64]  A. D’Andrea,et al.  The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. , 2000, Blood.

[65]  R. Braun,et al.  Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. , 1996, Blood.

[66]  Hans Joenje,et al.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 , 2007, Nature Genetics.

[67]  S. Sarkar,et al.  DNA interstrand crosslink repair during G1 involves nucleotide excision repair and DNA polymerase ζ , 2006, The EMBO journal.

[68]  Anindya Dutta,et al.  UBE2T, the Fanconi Anemia Core Complex, and FANCD2 Are Recruited Independently to Chromatin: a Basis for the Regulation of FANCD2 Monoubiquitination , 2007, Molecular and Cellular Biology.

[69]  S. Gasser,et al.  ATR/Mec1: coordinating fork stability and repair. , 2009, Current opinion in cell biology.

[70]  S. West,et al.  Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. , 2007, Molecular cell.

[71]  David A. Williams,et al.  Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M. , 2009, Blood.

[72]  Katsuhiro Hanada,et al.  The structure‐specific endonuclease Mus81–Eme1 promotes conversion of interstrand DNA crosslinks into double‐strands breaks , 2006, The EMBO journal.

[73]  J. Hoeijmakers,et al.  First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. , 2007, American journal of human genetics.

[74]  D. Schild,et al.  Mutants of the Five Rad51 Paralogs Recombinational Repair in Knockout Chromosome Instability and Defective , 2022 .

[75]  Bo Xu,et al.  Convergence of the Fanconi Anemia and Ataxia Telangiectasia Signaling Pathways , 2002, Cell.

[76]  B. Seed,et al.  Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. , 2001, Blood.

[77]  Hans Joenje,et al.  Biallelic Inactivation of BRCA2 in Fanconi Anemia , 2002, Science.

[78]  S. Cantor,et al.  Analysis of the DNA Substrate Specificity of the Human BACH1 Helicase Associated with Breast Cancer* , 2005, Journal of Biological Chemistry.

[79]  A. D’Andrea,et al.  The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. , 2002, Blood.

[80]  P. McHugh,et al.  Defining the Roles of Nucleotide Excision Repair and Recombination in the Repair of DNA Interstrand Cross-Links in Mammalian Cells , 2000, Molecular and Cellular Biology.

[81]  M. Buchwald,et al.  Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1 , 2001, Nature Medicine.

[82]  I. Hickson,et al.  Replication stress induces sister-chromatid bridging at fragile site loci in mitosis , 2009, Nature Cell Biology.

[83]  Leonard Wu,et al.  Role of the BLM helicase in replication fork management. , 2007, DNA repair.

[84]  Hongbing Shen,et al.  Association of Common PALB2 Polymorphisms with Breast Cancer Risk: A Case-Control Study , 2008, Clinical Cancer Research.

[85]  S. Cantor,et al.  BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. , 2005, Cancer cell.

[86]  Kok-Lung Chan,et al.  BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges , 2007, The EMBO journal.

[87]  James B. Mitchell,et al.  Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice. , 2008, Cancer research.

[88]  G. Pals,et al.  X-linked inheritance of Fanconi anemia complementation group B , 2004, Nature Genetics.

[89]  S. Boulton,et al.  C. elegans FANCD2 responds to replication stress and functions in interstrand cross-link repair. , 2006, DNA repair.

[90]  D. Papadopoulo,et al.  Decreased mutagenicity in Fanconi's anemia lymphoblasts following treatment with photoactivated psoralens. , 1990, Progress in clinical and biological research.

[91]  Fumio Hanaoka,et al.  Crystal structure of thymine DNA glycosylase conjugated to SUMO-1 , 2005, Nature.

[92]  G. Eichele,et al.  Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 , 1997, Nature.

[93]  H. Arakawa,et al.  Fanconi Anemia Protein FANCD2 Promotes Immunoglobulin Gene Conversion and DNA Repair through a Mechanism Related to Homologous Recombination , 2005, Molecular and Cellular Biology.

[94]  A. Auerbach,et al.  Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens , 1976, Nature.

[95]  A. D’Andrea,et al.  A novel diagnostic screen for defects in the Fanconi anemia pathway. , 2002, Blood.

[96]  J. Mi,et al.  Phosphorylation of Fanconi Anemia (FA) Complementation Group G Protein, FANCG, at Serine 7 Is Important for Function of the FA Pathway* , 2004, Journal of Biological Chemistry.

[97]  Thomas Helleday,et al.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.

[98]  Z. Dominski.  Nucleases of the Metallo-β-lactamase Family and Their Role in DNA and RNA Metabolism , 2007, Critical reviews in biochemistry and molecular biology.

[99]  C G Mathew,et al.  Isolation of a cDNA representing the Fanconi anemia complementation group E gene. , 2000, American journal of human genetics.

[100]  J. Haber,et al.  Yeast Mph1 helicase dissociates Rad51-made D-loops: implications for crossover control in mitotic recombination. , 2009, Genes & development.

[101]  K. Shin‐ya,et al.  FANCJ Helicase Defective in Fanconia Anemia and Breast Cancer Unwinds G-Quadruplex DNA To Defend Genomic Stability , 2008, Molecular and Cellular Biology.

[102]  Steven P. Gygi,et al.  UAF1 Is a Subunit of Multiple Deubiquitinating Enzyme Complexes* , 2009, Journal of Biological Chemistry.

[103]  C. Mathew,et al.  Interaction of FANCD2 and NBS1 in the DNA damage response , 2002, Nature Cell Biology.

[104]  H. Kitao,et al.  A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. , 2005, Molecular cell.

[105]  R. Kanaar,et al.  Repair of DNA interstrand cross-links. , 2001, Mutation research.

[106]  E. Friedberg,et al.  REV1 protein interacts with PCNA: significance of the REV1 BRCT domain in vitro and in vivo. , 2006, Molecular cell.

[107]  Hiroshi Arakawa,et al.  Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM , 2005, The EMBO journal.

[108]  M. Kastan,et al.  The ATM-dependent DNA damage signaling pathway. , 2005, Cold Spring Harbor symposia on quantitative biology.

[109]  Akiko Shimamura,et al.  Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. , 2007, The Journal of clinical investigation.

[110]  F. Rosselli,et al.  The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities , 2009, Nature Cell Biology.

[111]  S. Boulton,et al.  DOG-1 Is the Caenorhabditis elegans BRIP1/FANCJ Homologue and Functions in Interstrand Cross-Link Repair , 2007, Molecular and Cellular Biology.

[112]  John A Tainer,et al.  Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template. , 2007, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[113]  A. D’Andrea,et al.  Functional Interaction of Monoubiquitinated FANCD2 and BRCA2/FANCD1 in Chromatin , 2004, Molecular and Cellular Biology.

[114]  N. Yamada,et al.  How Fanconi anemia proteins promote the four Rs: Replication, recombination, repair, and recovery , 2005, Environmental and molecular mutagenesis.

[115]  O. Schärer,et al.  DNA Interstrand Crosslinks: Natural and Drug‐Induced DNA Adducts that Induce Unique Cellular Responses , 2005, Chembiochem : a European journal of chemical biology.

[116]  A. D’Andrea,et al.  Molecular pathogenesis of Fanconi anemia: recent progress. , 2006, Blood.

[117]  P. Perry,et al.  Cytological detection of mutagen–carcinogen exposure by sister chromatid exchange , 1975, Nature.

[118]  Weidong Wang,et al.  A Multiprotein Nuclear Complex Connects Fanconi Anemia and Bloom Syndrome , 2003, Molecular and Cellular Biology.

[119]  Weidong Wang,et al.  FAAP100 is essential for activation of the Fanconi anemia‐associated DNA damage response pathway , 2007, The EMBO journal.

[120]  René Bernards,et al.  The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. , 2005, Molecular cell.

[121]  T. M. Rünger,et al.  Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light. , 2006, Cancer research.

[122]  Wen-Hwa Lee,et al.  BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. , 2002, Science.

[123]  A. D’Andrea,et al.  S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. , 2002, Blood.

[124]  J. Hoeijmakers,et al.  The Structure-Specific Endonuclease Ercc1-Xpf Is Required To Resolve DNA Interstrand Cross-Link-Induced Double-Strand Breaks , 2004, Molecular and Cellular Biology.

[125]  A. Auerbach.  A test for Fanconi's anemia [letter] , 1988 .

[126]  Hans Joenje,et al.  FANCE: the link between Fanconi anaemia complex assembly and activity , 2002, The EMBO journal.

[127]  A. Gurtan,et al.  The WD40 Repeats of FANCL Are Required for Fanconi Anemia Core Complex Assembly* , 2006, Journal of Biological Chemistry.

[128]  C. Vandenberg,et al.  The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair , 2005, Nature Genetics.

[129]  M. Whitby,et al.  The FANCM Ortholog Fml1 Promotes Recombination at Stalled Replication Forks and Limits Crossing Over during DNA Double-Strand Break Repair , 2008, Molecular cell.

[130]  C. Mathew,et al.  Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors , 2003, Nature Medicine.

[131]  C. Mathew,et al.  Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer , 2007, Nature Genetics.

[132]  S. Elledge,et al.  FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway , 2008, Nature Structural &Molecular Biology.

[133]  R. Brosh,et al.  Welcome the Family of FANCJ-like Helicases to the Block of Genome Stability Maintenance Proteins , 2009, Cellular and Molecular Life Sciences.

[134]  M. Grompe,et al.  DNA Replication Is Required To Elicit Cellular Responses to Psoralen-Induced DNA Interstrand Cross-Links , 2000, Molecular and Cellular Biology.

[135]  A. Gurtan,et al.  Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. , 2008, Blood.

[136]  N. Howlett,et al.  The Fanconi anemia protein interaction network: casting a wide net. , 2009, Mutation research.

[137]  F. Larminat,et al.  Deficiency in BRCA2 leads to increase in non-conservative homologous recombination , 2002, Oncogene.

[138]  Andrzej Stasiak,et al.  The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. , 2008, Molecular cell.

[139]  H. Mohrenweiser,et al.  Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[140]  Weidong Wang,et al.  FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. , 2008, Human molecular genetics.

[141]  J. Sale,et al.  Deubiquitination of FANCD2 Is Required for DNA Crosslink Repair , 2007, Molecular cell.

[142]  F. Rosselli,et al.  The DNA crosslink‐induced S‐phase checkpoint depends on ATR–CHK1 and ATR–NBS1–FANCD2 pathways , 2004, The EMBO journal.

[143]  Zhao-Qi Wang,et al.  Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[144]  Jorge S. Reis-Filho,et al.  Resistance to therapy caused by intragenic deletion in BRCA2 , 2008, Nature.

[145]  A. D’Andrea,et al.  Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis. , 2009, Genes & development.

[146]  S. Elledge,et al.  FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. , 2008, Molecular cell.

[147]  Q. Waisfisz,et al.  Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. , 2006, Mutation research.

[148]  Hans Joenje,et al.  Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA , 1996, Nature Genetics.

[149]  C. McKerlie,et al.  Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia , 1996, Nature Genetics.

[150]  A. Gurtan,et al.  Structural Determinants of Human FANCF Protein That Function in the Assembly of a DNA Damage Signaling Complex* , 2007, Journal of Biological Chemistry.

[151]  C. Bishop,et al.  A novel gene, Pog, is necessary for primordial germ cell proliferation in the mouse and underlies the germ cell deficient mutation, gcd. , 2002, Human molecular genetics.

[152]  S. Elledge,et al.  Identification of the FANCI Protein, a Monoubiquitinated FANCD2 Paralog Required for DNA Repair , 2007, Cell.

[153]  Steven P Gygi,et al.  A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. , 2007, Molecular cell.

[154]  S. Cantor,et al.  FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A and interacts physically and functionally with the single-stranded DNA-binding protein. , 2007, Blood.

[155]  R. Marcos,et al.  Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability , 2007, The EMBO journal.

[156]  R. Camerini-Otero,et al.  Characterization of the DNA Damage-inducible Helicase DinG from Escherichia coli* , 2003, Journal of Biological Chemistry.

[157]  Hans Joenje,et al.  The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM , 2000, Nature Genetics.

[158]  A. D’Andrea,et al.  ATR couples FANCD2 monoubiquitination to the DNA-damage response. , 2004, Genes & development.

[159]  L. Thompson,et al.  The Fanconi anemia pathway limits the severity of mutagenesis. , 2006, DNA repair.

[160]  H. Arakawa,et al.  Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde. , 2007, Cancer research.

[161]  K. J. Patel,et al.  The Walker B motif in avian FANCM is required to limit sister chromatid exchanges but is dispensable for DNA crosslink repair , 2009, Nucleic acids research.

[162]  Christopher G Mathew,et al.  Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. , 2004, Human molecular genetics.

[163]  F. Couch,et al.  Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. , 2006, Molecular cell.

[164]  Weidong Wang,et al.  Evidence for subcomplexes in the Fanconi anemia pathway. , 2006, Blood.

[165]  S. West,et al.  Structural and functional relationships of the XPF/MUS81 family of proteins. , 2008, Annual review of biochemistry.

[166]  Hans Joenje,et al.  The genetic and molecular basis of Fanconi anemia. , 2009, Mutation research.

[167]  L. Pellegrini,et al.  Insights into Fanconi Anaemia from the structure of human FANCE , 2007, Nucleic acids research.

[168]  C. Mathew,et al.  FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3 , 2008, Oncogene.

[169]  J. Hoeijmakers,et al.  Reduced hematopoietic reserves in DNA interstrand crosslink repair‐deficient Ercc1−/− mice , 2005, The EMBO journal.

[170]  P. McHugh,et al.  DNA Interstrand Cross-Link Repair in the Saccharomyces cerevisiae Cell Cycle: Overlapping Roles for PSO2 (SNM1) with MutS Factors and EXO1 during S Phase , 2005, Molecular and Cellular Biology.

[171]  R. Shiekhattar,et al.  Activation of BRCA1/BRCA2-Associated Helicase BACH1 Is Required for Timely Progression through S Phase , 2007, Molecular and Cellular Biology.